Sernova Biotherapeutics

(TSX) SVA

Current PriceCA$0.14

Market CapCA$50.98M

Since IPO (2000)-96%

5 Year-91%

1 Year-13%

1 Month-4%

Sernova Biotherapeutics Financials at a Glance

Market Cap

CA$50.98M

Revenue (TTM)

CA$0.00

Net Income (TTM)

-CA$11.83M

EPS (TTM)

-CA$0.04

P/E Ratio

-3.85

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Price

CA$0.14

Volume

8,764

Open

CA$0.14

Price

CA$0.14

Volume

8,764

Open

CA$0.14

Previous Close

CA$0.14

Daily Range

CA$0.14 - CA$0.14

52-Week Range

CA$0.12 - CA$0.21

Estimated Earnings Date

Sep 10, 2026

Dividend

CA$0.00

Beta (Volatility)

0.48 (Low)

Price

CA$0.14

Volume

8,764

Open

CA$0.14

Previous Close

CA$0.14

Daily Range

CA$0.14 - CA$0.14

52-Week Range

CA$0.12 - CA$0.21

Estimated Earnings Date

Sep 10, 2026

SVA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sernova Biotherapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jonathan M. N. Rigby, MBA

Website

www.sernova.com

Headquarters

London, ON N6G 4X8, GB

SVA Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

55.85%

Return on Capital

N/A

Return on Assets

-771.32%

Earnings Yield

-25.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$50.98M

Shares Outstanding

377.64M

Volume

8.76K

Avg. Volume

129.88K

Financials (TTM)

Gross Profit

-CA$256.13K

Operating Income

-CA$10.28M

EBITDA

-CA$10.22M

Operating Cash Flow

-CA$5.50M

Capital Expenditure

-CA$4.00

Free Cash Flow

-CA$5.50M

Cash & ST Invst.

CA$1.05M

Total Debt

CA$2.45M

Sernova Biotherapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

CA$0.00

N/A

Gross Profit

-CA$4.43K

+90.7%

Gross Margin

0.00%

N/A

Market Cap

CA$50.98M

N/A

Market Cap/Employee

CA$3.00M

N/A

Employees

N/A

Net Income

-CA$3.23M

+14.5%

EBITDA

-CA$2.30M

+33.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

CA$1.05M

-47.3%

Total Debt

CA$2.45M

-48.2%

Accounts Receivable

CA$116.84K

-73.0%

Inventory

CA$0.00

N/A

Long Term Debt

CA$229.24K

-81.2%

Short Term Debt

CA$2.22M

-36.8%

Return on Assets

-7.71%

N/A

Return on Invested Capital

1.09%

N/A

Free Cash Flow

-CA$2.21M

+42.5%

Operating Cash Flow

-CA$2.21M

+42.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MIR.VMedMira Inc.

MIR.VMedMira Inc.CA$0.07+0.00%

COV.VCovalon Technologies Ltd.

COV.VCovalon Technologies Ltd.CA$2.10+0.00%

MBX.TOMicrobix Biosystems Inc.

MBX.TOMicrobix Biosystems Inc.CA$0.30+0.00%

RVX.TOResverlogix Corp.

RVX.TOResverlogix Corp.CA$0.10+5.56%

BCT.TOBriaCell Therapeutics Corp.

BCT.TOBriaCell Therapeutics Corp.CA$4.47-3.66%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.64-0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.79+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.38+0.01%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$5.53+0.10%

MARAMara Holdings

MARAMara Holdings$13.30-0.01%

TAT&T

TAT&T$20.53+0.00%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$12.83+0.05%

Questions About SVA

What is the current price of Sernova Biotherapeutics?

Sernova Biotherapeutics is trading at CA$0.14 per share.

What is the 52-week range for Sernova Biotherapeutics?

Over the past 52 weeks, Sernova Biotherapeutics has traded between CA$0.12 and CA$0.21.

How much debt does Sernova Biotherapeutics have?

As of the most recent reporting period, Sernova Biotherapeutics reported total debt of CA$2.45M.

How much cash does Sernova Biotherapeutics have on hand?

Sernova Biotherapeutics reported CA$1.05M in cash and cash equivalents in its most recent financial results.

What is Sernova Biotherapeutics’s dividend yield?

Sernova Biotherapeutics does not currently have a dividend yield.

Sernova Biotherapeutics

Sernova Biotherapeutics Financials at a Glance

SVA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sernova Biotherapeutics

SVA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sernova Biotherapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SVA

What is the current price of Sernova Biotherapeutics?

What is the 52-week range for Sernova Biotherapeutics?

How much debt does Sernova Biotherapeutics have?

How much cash does Sernova Biotherapeutics have on hand?

What is Sernova Biotherapeutics’s dividend yield?

Premium Investing Services